Apoptosis Market

Date: 2016-05

Programmed self destruction of damaged or abnormal cells is termed as apoptosis. When cells in multicellular organism are no longer required, intracellular destrcuction of the cells begins. However, excessive and insufficient apoptotic processes have been known to be associated with several diseases. While excessive apoptosis is attributed to atrophy, an insuffienct apoptosis can result in an uncontrolled proliferation of unwanted cells and can result in cancer. There are several other diseases such as neurodegenerative diseases such as Alzeihmer’s, Huntinton’s and ALS and other autoimmune diseases that are stem from either a failure of apoptosis in elimination of harmful cells or unwanted activation of apoptosis that can result in destruction of important cells. Several drugs available in the market and those currently being research exhibit apoptosis modulating properties.

Rising number of cancer detected patients across the globe is one of the main drivers for the apoptosis market. Research and development efforts by companies as well as universities, sometimes in collaboration, is another factor augmenting the growth of this market. Lack of awareness is one factor that can potentially restrain the growth of this market.

An important section on patent analysis is included in this report that explores some of the most influential patents and potential indications for apoptosis modulation.Apoptosis Market

The Apoptosis market can be segmented on the basis of mechanism as:
Bcl-2 Modulators
Caspase Activators and Inhibitors
p53 Modulators
Protease/Proteasome Inhibitors
Molecular Pathways

The Apoptosis market has also been segmented on the basis of the class of drugs as:
Direct apoptogens
First generation indirect apoptogens
second generation indirect apoptogens
reagents and kits

One of the main application of apoptosis is for the treatment of cancer.
In terms of type of disease treatment, the Apoptosis market has been segmented across the following diseases:
Neurodegenerative diseases
Cardiovascular Diseases

North America currenlty accounts for the largest share of the global apoptosis market with Europe coming a close second. The market in emerging and developing economies in APAC and South America are expected to grow at higher rates comparatively till the end of the forecast period.

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Apoptosis market:
Amgen Inc
Abbott Laboratories
Aegera Therapeutics Inc

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample